Immunization with High-Dose Intradermal Recombinant Hepatitis B Vaccinein Healthcare Workers Who Failed to Respond to Intramuscular Vaccination
Infection Control and Hospital Epidemiology1995Vol. 16(2), pp. 88–91
Citations Over TimeTop 10% of 1995 papers
Abstract
We conclude that intradermal vaccination is efficacious in the majority of healthcare workers who failed to respond to intramuscular vaccine. Further studies, including randomized comparisons with intramuscular vaccine as well as studies of cell-mediated immunity, appear warranted.
Related Papers
- → A Novel Technique to Reduce Pain from Intradermal Injection of Botulinum Toxin Type A(2021)13 cited
- → Rapid immunization effects of a new type of 60 μg hepatitis B vaccine compared with traditional 20 μg hepatitis B vaccines in adults(2016)7 cited
- Follow-up of infants vaccinated hepatitis B vaccine born by women with three signs positive(2005)
- Epidemiological Study on HBV Serum in Qidong,2011(2013)
- The Descetn and Ascent Dynamics of Neutrolizing Antibodies of Recombinant Fowlpox virus Coexpressing NDV FGene and IBDV VP0 Gene(2006)